Cargando…
Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants
Type 1 diabetes (T1D) is caused by the chronic autoimmune destruction of insulin producing beta cells. Beta cell replacement therapy through whole pancreas or islet transplantation is a therapeutic option for patients in which a stable glucose control is not achievable with exogenous insulin therapy...
Autores principales: | Monti, Paolo, Vignali, Debora, Piemonti, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398085/ https://www.ncbi.nlm.nih.gov/pubmed/25777058 http://dx.doi.org/10.2174/1573399811666150317125820 |
Ejemplares similares
-
Homeostatic T Cell Proliferation after Islet Transplantation
por: Monti, Paolo, et al.
Publicado: (2013) -
Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
por: Di Dedda, Carla, et al.
Publicado: (2019) -
Current Status of Pancreas and Islet Cell Transplantation
por: Saidi, R. F.
Publicado: (2012) -
Australia and New Zealand Islet and Pancreas Transplant Registry Annual Report 2018—Islet Donations, Islet Isolations, and Islet Transplants
por: Webster, Angela C., et al.
Publicado: (2019) -
Australia and New Zealand Islet and Pancreas Transplant Registry Annual Report 2019: Islet Donations, Islet Isolations, and Islet Transplants
por: Webster, Angela C., et al.
Publicado: (2020)